4.7 Article

An area under the concentration-time curve threshold as a predictor of efficacy and nephrotoxicity for individualizing polymyxin B dosing in patients with carbapenem-resistant gram-negative bacteria

Journal

CRITICAL CARE
Volume 26, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13054-022-04195-7

Keywords

Polymyxin B; AUC(ss 24 h) threshold; Nephrotoxicity; Efficacy; Therapeutic drug monitoring

Funding

  1. National Key R&D Program of China [2020YFC2008304]

Ask authors/readers for more resources

This study aimed to establish an AUC(ss,24 h) threshold for polymyxin B, finding that an AUC(ss,24 h) threshold of 50-100 mg h/L was associated with decreased nephrotoxicity while assuring clinical efficacy for critically ill patients.
Background Evidence supports therapeutic drug monitoring of polymyxin B, but clinical data for establishing an area under the concentration-time curve across 24 h at steady state (AUC(ss,24 h)) threshold are still limited. This study aimed to examine exposure-response/toxicity relationship for polymyxin B to establish an AUC(ss,24 h) threshold in a real-world cohort of patients. Methods Using a validated Bayesian approach to estimate AUC(ss,24 h) from two samples, AUC(ss,24 h) threshold that impacted the risk of polymyxin B-related nephrotoxicity and clinical response were derived by classification and regression tree (CART) analysis and validated by Cox regression analysis and logical regression analysis. Results A total of 393 patients were included; acute kidney injury (AKI) was 29.0%, clinical response was 63.4%, and 30-day all-cause mortality was 35.4%. AUC(ss,24 h) thresholds for AKI of > 99.4 mg h/L and clinical response of > 45.7 mg h/L were derived by CART analysis. Cox and logical regression analyses showed that AUC(ss,24 h) of > 100 mg h/L was a significant predictor of AKI (HR 16.29, 95% CI 8.16-30.25, P < 0.001) and AUC(ss,24 h) of >= 50 mg h/L (OR 4.39, 95% CI 2.56-7.47, P < 0.001) was independently associated with clinical response. However, these exposures were not associated with mortality. In addition, the correlation between trough concentration (1.2-2.8 mg/L) with outcomes was similar to AUC(ss,24 h). Conclusions For critically ill patients, AUC(ss,24 h) threshold of 50-100 mg h/L was associated with decreased nephrotoxicity while assuring clinical efficacy. Therapeutic drug monitoring is recommended for individualizing polymyxin B dosing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available